Name: Boston Scientific Corp. (NYSE:BSX) | Balance Sheet: Assets (Quarterly)
Creator: Stock Analysis on Net

Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Boston Scientific Corp., consolidated balance sheet: assets (quarterly data)

US$ in millions

	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018
Cash and cash equivalents	570)	928)	338)	276)	325)	1,925)	1,947)	2,675)	2,016)	1,734)	2,022)	1,724)	370)	217)	277)	123)	139)	146)	168)	208)	287)
Trade accounts receivable, net	2,076)	1,970)	1,871)	1,917)	1,866)	1,778)	1,669)	1,675)	1,631)	1,531)	1,598)	1,457)	1,577)	1,828)	1,796)	1,712)	1,621)	1,608)	1,580)	1,587)	1,580)
Inventories	2,050)	1,867)	1,788)	1,752)	1,736)	1,610)	1,603)	1,430)	1,407)	1,351)	1,472)	1,516)	1,628)	1,579)	1,566)	1,300)	1,228)	1,166)	1,134)	1,087)	1,113)
Prepaid income taxes	296)	264)	262)	264)	249)	205)	217)	202)	192)	194)	174)	181)	205)	195)	189)	175)	163)	161)	43)	46)	50)
Assets held for sale	—)	—)	—)	—)	—)	—)	—)	—)	—)	1,133)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Other current assets	712)	731)	885)	874)	889)	799)	793)	776)	855)	751)	894)	925)	1,043)	880)	1,019)	3,024)	3,083)	922)	1,046)	1,001)	1,050)
Current assets	5,704)	5,760)	5,144)	5,083)	5,065)	6,317)	6,229)	6,758)	6,101)	6,694)	6,160)	5,803)	4,823)	4,699)	4,847)	6,334)	6,234)	4,003)	3,971)	3,929)	4,080)
Property, plant and equipment, net	2,478)	2,446)	2,273)	2,246)	2,265)	2,252)	2,109)	2,082)	2,053)	2,084)	2,064)	2,079)	2,098)	2,079)	1,942)	1,820)	1,782)	1,782)	1,730)	1,715)	1,700)
Goodwill	13,269)	12,920)	12,852)	12,883)	12,949)	11,988)	11,820)	10,874)	10,868)	9,951)	10,137)	10,101)	10,098)	10,176)	10,015)	8,451)	8,179)	7,911)	7,588)	7,242)	6,984)
Other intangible assets, net	6,060)	5,902)	6,058)	6,349)	6,581)	6,121)	6,227)	5,788)	5,991)	5,917)	6,797)	7,160)	7,393)	7,886)	8,074)	6,486)	6,448)	6,372)	6,297)	5,934)	5,713)
Deferred tax assets	3,900)	3,942)	4,018)	4,059)	4,102)	4,142)	4,049)	4,036)	4,173)	4,210)	4,172)	4,182)	4,162)	4,196)	—)	—)	—)	—)	—)	—)	—)
Other long-term assets	1,481)	1,499)	1,602)	1,569)	1,375)	1,409)	1,443)	1,630)	1,714)	1,921)	1,515)	1,498)	1,539)	1,529)	1,878)	1,218)	1,159)	931)	793)	795)	725)
Long-term assets	27,188)	26,709)	26,803)	27,106)	27,272)	25,912)	25,648)	24,410)	24,799)	24,083)	24,685)	25,020)	25,290)	25,866)	21,909)	17,975)	17,568)	16,996)	16,408)	15,686)	15,122)
Total assets	32,892)	32,469)	31,947)	32,189)	32,337)	32,229)	31,877)	31,168)	30,900)	30,777)	30,845)	30,823)	30,113)	30,565)	26,756)	24,309)	23,802)	20,999)	20,379)	19,615)	19,202)

Total assets exhibited a consistent upward trajectory over the analyzed period, growing from 19,202 million USD in March 2018 to 32,892 million USD by March 2023. This represents a substantial expansion of the balance sheet, driven primarily by an increase in long-term assets and strategic acquisitions.

Liquidity and Current Asset Trends: Cash and cash equivalents demonstrated significant volatility. Following a period of decline between March 2018 and June 2019, where balances reached a low of 123 million USD, a sharp increase occurred during 2020 and 2021, peaking at 2,675 million USD in June 2021. By March 2023, this figure retracted to 570 million USD, indicating periodic fluctuations in liquidity management or capital allocation.; Trade accounts receivable and inventories showed a steady long-term increase. Receivables grew from 1,580 million USD in March 2018 to 2,076 million USD in March 2023, while inventories rose from 1,113 million USD to 2,050 million USD over the same period. These trends suggest a scaling of operations and an increase in working capital requirements.
Long-Term Asset Composition: Goodwill experienced the most pronounced growth of any asset category, increasing from 6,984 million USD in March 2018 to 13,269 million USD in March 2023. This nearly twofold increase indicates a sustained strategy of growth through acquisitions.; Property, plant, and equipment (PPE) followed a gradual growth pattern, rising from 1,700 million USD to 2,478 million USD, reflecting incremental investments in physical infrastructure.; Other intangible assets, net, peaked in September 2019 at 8,074 million USD before stabilizing and ending the period at 6,060 million USD in March 2023, suggesting periodic amortization or impairment offset by new acquisitions.
Structural Balance Sheet Shifts: A notable structural change occurred in December 2019 with the appearance of deferred tax assets totaling 4,196 million USD, which remained a consistent component of the long-term asset base through March 2023.; The overall asset mix shifted toward a higher concentration of non-current assets. Long-term assets grew from 15,122 million USD in March 2018 to 27,188 million USD in March 2023, while current assets moved from 4,080 million USD to 5,704 million USD, emphasizing the company's reliance on long-term intangible value and infrastructure to drive its asset base.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?

Boston Scientific Corp. (NYSE:BSX)

Balance Sheet: AssetsQuarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data